Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2
Supplementary Data
- Supplementary Figure 1 -
(a) Western blot show the effect of treatment with Compound C (CC) and Docetaxel on the
abundance on IGFBP-2 in LNCaP cells. (b) Changes in % cell death of LNCaP cells according to different treatment. LNCaP cells
were set up as described in Fig 1a and pre-treated with 2μM Compound C for 1hr then
dosed with 60nM Docetaxel and 5mM Metformin for 24hrs. Cell death was evaluated using
trypan blue cell counting (n=3). (PDF 300 KB)
-
Published online before print
October 17, 2016,
doi:
10.1530/ERC-16-0095
Endocr Relat Cancer
January 1, 2017
vol. 24
no. 1
17-30